Washington. The United States is the most affected by the coronavirus in the world. So far more than 64 thousand people have died due to the deadly virus in the country. Meanwhile, many US hospitals continue to use malaria drug Hydroxychloroquine to treat patients infected with Covid-19.
Medical publication, MDedge reported on Friday that the malaria drug hydroxychloroquine (HQC) is currently the first-line therapy to treat people infected with the coronavirus, while tocilizumab is a second-line drug for hospitalized people.
Indian American cardiologist Nihar Desai told the medical publication that hydroxychloroquine is the first line at Yale as the data shows the potential inhibition of the virus and the potential clinical benefits, which is quite good as evidence at the moment.
He said that it is cheap, has been used for decades and people are relatively comfortable with it. Desai told MDs that we are trying to do what we can. There is an expectation that we will never have to go through this (coronavirus epidemic) again. The report states that Yale-New Haven Hospital is nearly half full of coronavirus patients. There are more than 400 infected patients here.
On Friday, the US Food and Drug Administration approved the use of anti-viral remediesvir for the treatment of coronavirus patients. Explain that hydroxychloroquine was the first drug to receive FAU from the FDA for the treatment of Corona patients.
US President Donald Trump has been an advocate for the use of hydroxychloroquine, which has reportedly cured patients in New York and many other places. Reports suggest that the malaria drug has been effective in the early stages of a person infected with the coronavirus, but is at risk for heart diseases. At the request of President Trump, India exported 50 million hydroxychloroquine tablets to the United States.